News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
245 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (4)
2 (2)
3 (20)
4 (246)
5 (293)
6 (243)
7 (134)
8 (6)
9 (6)
10 (245)
11 (212)
12 (305)
13 (245)
14 (103)
15 (11)
16 (7)
17 (226)
18 (253)
19 (250)
20 (220)
21 (147)
22 (16)
23 (11)
24 (235)
25 (299)
26 (248)
27 (114)
28 (103)
29 (10)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
Array BioPharma Announces Publication of BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) Phase 3 Overall Survival Data in The Lancet Oncology
- BRAFTOVI + MEKTOVI demonstrated a median overall survival of 33.6 months in patients with advanced BRAF-mutant melanoma in Phase 3 COLUMBUS trial -
September 13, 2018
·
14 min read
Business
Blink Fitness Opens Its Newest New Jersey Location In Plainfield
Blink Fitness, the premium-quality, value gym, is excited to announce the grand opening of its 71st location, in Plainfield.
September 13, 2018
·
4 min read
Pharm Country
PTC Therapeutics to Participate at Upcoming Investor Conference on September 27 2018
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at Jefferies Gene Therapy Summit on Thursday, September 27th at 1:30 p.m. EST.
September 13, 2018
·
1 min read
Business
In Celebration of Intergeneration Month: Senior Living Designer, Lisa Cini, Offers Personal Insights to Inspire Intergenerational Living
Intergeneration Month is a time to connect generations, and Lisa Cini, renowned senior living expert and multigenerational household enthusiast, documents what it took to make a four-generation home work in her book Hive: The Simple Guide to Multigenerational Living - How Our Family Makes it Work.
September 13, 2018
·
2 min read
Drug Development
Millendo Therapeutics Announces Initiation of Phase 2b Clinical Trial of Nevanimibe in Patients with Classic Congenital Adrenal Hyperplasia
Evaluates the efficacy and safety of its novel drug candidate, nevanimibe, in patients with classic congenital adrenal hyperplasia.
September 13, 2018
·
3 min read
Global Healthcare IT Market 2018-2022 | Emergence of AI-enabled Emotion Recognition Technologies to Boost Growth | Technavio
The global healthcare IT market is expected to post a CAGR of over 8% during the period 2018-2022, according to the latest market research report by Technavio.
September 13, 2018
·
4 min read
Anthem Activates Plan to Help Residents in States Impacted by Hurricane Florence
Anthem subsidiaries offer pharmacy assistance for health plan consumers and free telehealth medical and psychological help for all residents
September 13, 2018
·
3 min read
Pharm Country
NIH selects Soligenix’s SGX942 in the Treatment of Oral Mucositis for the Commercialization Accelerator Program
The SGX942 program has been specifically selected by the NIH for the Commercialization Transition Track
September 13, 2018
·
10 min read
Business
BioArctic Signs a Research Agreement With Brain Biomarker Solutions in Gothenburg AB to Develop New Diagnostics for Alzheimer’s Disease
Collaboration is to develop new and improved diagnostic methods for Alzheimer’s disease by identifying and measuring new biomarkers in cerebrospinal fluid (CSF) and blood.
September 13, 2018
·
5 min read
Biotech Beach
Duchesnay Inc. to Present a Poster on Ospemifene at the 2018 Annual Meeting of the North American Menopause Society (NAMS)
Duchesnay Inc. announced today that it will present a poster on the topic of ospemifene at the 2018 Annual Meeting of the North American Menopause Society (NAMS) in San Diego.
September 13, 2018
·
2 min read
Previous
20 of 25
Next